Medicine and Dentistry
Apoplexy
100%
Meta-Analysis
67%
Cohort Analysis
55%
Randomized Controlled Trial
53%
Systematic Review
51%
Disease
47%
Magnetic Resonance Imaging
45%
Brain Ischemia
41%
Traumatic Brain Injury
40%
Neoplasm
38%
Symptom
34%
Bipolar Disorder
32%
Injury
32%
Hazard Ratio
31%
Rehabilitation Engineering
29%
Parkinson's Disease
26%
Computer Assisted Tomography
26%
Disability
25%
Odds Ratio
24%
Drug Therapy
22%
Glioblastoma
20%
Alzheimer's Disease
19%
Cerebral Hemorrhage
19%
Spinal Cord Injury
18%
Ganglioglioma
16%
Prevalence
16%
Diabetes
16%
Biological Marker
16%
Malignant Neoplasm
15%
Case-Control Study
14%
Placebo
14%
Quality of Life
14%
Logistic Regression Analysis
13%
Knee Osteoarthritis
13%
Bleeding
13%
Antidepressant
13%
In Vitro
13%
Radiation Therapy
13%
Surgery
13%
Outpatient
12%
Pediatrics
12%
Retrospective Cohort Study
12%
Major Depressive Episode
12%
Diabetes Mellitus
12%
Obstructive Sleep Apnea
12%
Supplementation
11%
Cognitive Defect
11%
Sarcopenia
11%
Diagnosis
11%
Proportional Hazards Model
11%
Adverse Event
11%
Functional Electrical Stimulation
11%
Motor Performance
11%
Osteoarthritis
11%
Upper Limb
11%
Medicine
10%
Neurologic Disease
10%
Knee
10%
Brain Tumor
10%
Arm
10%
Programmed Cell Death
10%
Metastatic Carcinoma
10%
Closed Head Injury
10%
Mortality Rate
9%
Visual Analog Scale
9%
Epileptic Seizure
9%
Percutaneous Vertebroplasty
9%
Cardiovascular Disease
9%
Resistance Training
9%
Body Mass Index
9%
Blood Clot Lysis
9%
Electrical Brain Stimulation
9%
Magnetic Resonance Imaging
9%
Alcoholic Polyneuropathy
9%
Retrospective Study
8%
Typical Antipsychotic
8%
Clinical Trial
8%
Cognition
8%
Headache
8%
Electrostimulation
8%
Alteplase
8%
Nuclear Magnetic Resonance
8%
Cross Sectional Study
8%
Hip Fracture
8%
Clinician
8%
Combination Therapy
8%
Stereotactic Radiosurgery
8%
International Classification of Impairments, Disabilities and Handicaps
7%
Network Meta-Analysis
7%
Artery
7%
Lower Limb
7%
Recurrent Disease
7%
Mesenchymal Stem Cell
7%
Leg
7%
Gamma Knife Radiosurgery
7%
Population
7%
Infarction
7%
Depression
7%
Infection
7%
Maturity Onset Diabetes of the Young
7%
Neuroscience
Brain Ischemia
80%
Neurotrauma
79%
Traumatic Brain Injury
79%
Meta-Analysis
69%
Bipolar Disorder
64%
Dementia Praecox
59%
Parkinson's Disease
54%
Randomized Controlled Trial
37%
Alzheimer's Disease
35%
Cognitive Disorders
35%
Magnetic Resonance Imaging
31%
Magnetic Resonance Imaging
27%
Major Depressive Disorder
25%
Cerebral Hemorrhage
24%
Obstructive Sleep Apnea
22%
In Vivo
21%
Antidepressant
20%
Cognitive Function
20%
Spinal Cord Injury
19%
Behavior (Neuroscience)
19%
Typical Antipsychotic
18%
Depression
17%
In Vitro
16%
Placebo
16%
Diabetes Mellitus
15%
Sleep Disorder
15%
Closed Head Injury
14%
Antipsychotic
14%
Oxidative Stress
14%
Middle Cerebral Artery
14%
Neuroprotective Agent
14%
Olanzapine
13%
Body Mass Index
13%
Transcranial Magnetic Stimulation
13%
Brain Tumor
13%
Functional Magnetic Resonance Imaging
12%
Ischemia
12%
Fibromyalgia
11%
Mesenchymal Stem Cell
11%
Sleep Quality
11%
Metabolic Pathway
11%
Heart Rate Variability
11%
Electrical Brain Stimulation
11%
Glioblastoma Multiforme
11%
Blood Brain Barrier
11%
Mental Disorder
10%
Diffusion Tensor Imaging
10%
Temozolomide
10%
Amyloid
10%
Functional Connectivity
10%
Clozapine
10%
Artificial Neural Network
10%
Neural Network
10%
Autophagy
9%
Cell Signaling
9%
Stem Cell
9%
Astrocyte
9%
Brain-Derived Neurotrophic Factor
9%
Neurodegenerative Disorder
8%
Computed Tomography
8%
Mild Cognitive Impairment
8%
Cerebrovascular Disease
8%
Bipolar I Disorder
8%
Hippocampus
8%
Cell Death
8%
Striatum
7%
Working Memory
7%
Stereotypic Movement Disorder
7%
Transcranial Direct Current Stimulation
7%
P53
7%
Adverse Effect
7%
Neuroprotection
7%
Reactive Oxygen Species
7%
Dopamine Release
6%
Bipolar Mania
6%
Alteplase
6%
Subarachnoid Hemorrhage
6%
Fractional Anisotropy
6%
Impulsivity
6%
Aspirin
6%
Staining Technique
6%
Attention Deficit Hyperactivity Disorder
6%
Hematoma
6%
Atrial Fibrillation
6%
Functional Electrical Stimulation
6%
Platelet
6%
Electroencephalography
6%
Promoter Region
6%
Physical Dependence
6%
Susceptibility Weighted Imaging
6%
Psychoactive Drug
5%
Polysomnography
5%
Arterial Spin Labeling
5%
Excitability
5%
Face
5%
Cell Line
5%
Sleep Time
5%
Oxytocin
5%
Longitudinal Study
5%
Glutamic Acid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
59%
Disease
53%
Brain Ischemia
40%
Glioblastoma
40%
Traumatic Brain Injury
39%
Randomized Controlled Trial
36%
Bipolar Disorder
33%
Injury
33%
Mouse
32%
Parkinson's Disease
31%
Malignant Neoplasm
27%
Neoplasm
27%
Symptom
23%
Inflammation
20%
Antipsychotic
19%
Prevalence
19%
Antidepressant
19%
Alzheimer's Disease
17%
Sleep Disordered Breathing
17%
Typical Antipsychotic
16%
Head Injury
14%
Adverse Event
14%
Olanzapine
14%
Brain Hemorrhage
13%
Nervous System Inflammation
13%
Lipopolysaccharide
13%
Major Depression
13%
Clozapine
13%
Cognitive Defect
12%
Temozolomide
12%
Clinical Trial
12%
Case-Control Study
11%
Comorbidity
11%
Neuroprotective Agent
11%
Biological Marker
11%
Placebo
11%
Combination Therapy
10%
Remission
10%
Spinal Cord Injury
10%
Diabetes Mellitus
10%
Reactive Oxygen Metabolite
10%
Metabolic Syndrome X
9%
Mortality Rate
9%
Chemotherapy
8%
Antioxidant
8%
Anti-Inflammatory Drug
8%
Survival Rate
8%
Sleep Disorder
8%
Recurrent Disease
8%
Alteplase
8%
Cardiovascular Disease
7%
Metformin
7%
Pharmacotherapy
7%
Cross-Sectional Study
7%
Tumor Necrosis Factor
7%
Chronic Kidney Failure
7%
Phosphotransferase
7%
Monotherapy
7%
Brain Tumor
7%
Acute Heart Infarction
7%
Neuroprotection
7%
Nitric Oxide
6%
Osteoarthritis
6%
Therapeutic Effect
6%
Mouse Model
6%
Rat Model
6%
Epidermal Growth Factor Receptor
6%
Pomalidomide
6%
Pathophysiology
6%
Non Small Cell Lung Cancer
6%
Triacylglycerol
6%
Cytokine
6%
Breast Cancer
6%
Heat Stroke
6%
Side Effect
6%
Bleeding
6%
Attention Deficit Disorder
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Statin (Protein)
6%
Deterioration
6%
Infarction
5%
Acetylsalicylic Acid
5%
Non Insulin Dependent Diabetes Mellitus
5%
Retrospective Study
5%
Insulin Resistance
5%
Amyloid
5%
Infection
5%
Liver Cell Carcinoma
5%
Histone Deacetylase Inhibitor
5%
Cytotoxicity
5%
Hyperlipidemia
5%
Cell Viability
5%
Caspase 3
5%
Cyclooxygenase 2
5%
Lung Cancer
5%
Sarcopenia
5%
Protein P53
5%
Risperidone
5%
Rheumatoid Arthritis
5%
Brain Injury
5%